Novo Nordisk sued over weight-loss drug spin. Now it’s doing the exact same thing

Novo Nordisk and Eli Lilly are battling for dominance in one of medicine’s largest and fastest-growing markets: drugs for obesity and weight loss.

On Monday, Novo announced encouraging results for........

© Washington Examiner